PMID- 11340305 OWN - NLM STAT- MEDLINE DCOM- 20010816 LR - 20191210 IS - 1018-7782 (Print) IS - 1018-7782 (Linking) VI - 9 IP - 3 DP - 2001 TI - Regulation of tubular cell MCP-1 production by intracellular ions: a role for sodium and calcium. PG - 205-13 AB - Proximal tubule cells (PTC) in chronic renal disease produce chemokines which cause renal interstitial inflammation, and also transport more Na+ than normal. To investigate whether these two events might be related, monocyte chemoattractant protein-1 (MCP-1) production was examined in rat PTC in primary culture. Amiloride reduced, while ouabain increased levels of MCP-1 mRNA and protein. Amiloride reduced MCP-1 in cells stimulated with ouabain, lipopolysaccharide (LPS) or albumin. Intracellular Na+ rose with ouabain, but not LPS or albumin. Effects of amiloride, ouabain, LPS and albumin were abrogated by sodium-free but not chloride-free culture medium, and were not explained by changes in intracellular pH. Intracellular Ca2+ rose with ouabain, LPS or albumin and sodium-free medium. BAPTA-AM reduced intracellular Ca2+ and MCP-1 mRNA levels in unstimulated cells, and cells stimulated with ouabain, LPS or albumin. Thus, amiloride and ouabain may alter tubular cell MCP-1 by changing intracellular Na+, with secondary changes in intracellular Ca2+, whereas stimulation by LPS and albumin may involve Ca2+ directly. CI - Copyright 2001 S. Karger AG, Basel FAU - Harris, D C AU - Harris DC AD - Department of Renal Medicine, The University of Sydney at Westmead Hospital, Westmead, NSW, Australia. dch@medicine.usyd.edu.au FAU - Wang, Y AU - Wang Y FAU - Campbell, D AU - Campbell D LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Switzerland TA - Exp Nephrol JT - Experimental nephrology JID - 9302239 RN - 0 (Chemokine CCL2) RN - 0 (Fluorescent Dyes) RN - 0 (Lipopolysaccharides) RN - 0 (RNA, Messenger) RN - 139890-68-9 (1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester) RN - 526U7A2651 (Egtazic Acid) RN - 5ACL011P69 (Ouabain) RN - 7DZO8EB0Z3 (Amiloride) RN - 9NEZ333N27 (Sodium) RN - EC 7.2.2.13 (Sodium-Potassium-Exchanging ATPase) RN - SY7Q814VUP (Calcium) RN - VW50CE070T (ethylisopropylamiloride) SB - IM MH - Acid-Base Equilibrium/physiology MH - Amiloride/analogs & derivatives/*pharmacology MH - Animals MH - Calcium/*metabolism MH - Cell Survival/physiology MH - Cells, Cultured MH - Chemokine CCL2/*antagonists & inhibitors/biosynthesis/physiology MH - Dose-Response Relationship, Drug MH - Egtazic Acid/analogs & derivatives/*pharmacology MH - Enzyme-Linked Immunosorbent Assay MH - Fluorescent Dyes MH - Hydrogen-Ion Concentration MH - Kidney Tubules, Proximal/*drug effects/metabolism MH - Lipopolysaccharides/*pharmacology MH - Male MH - Ouabain/*pharmacology MH - RNA, Messenger/*metabolism MH - Rats MH - Rats, Wistar MH - Reverse Transcriptase Polymerase Chain Reaction MH - Sodium/*metabolism MH - Sodium-Potassium-Exchanging ATPase/metabolism MH - Spectrometry, Fluorescence EDAT- 2001/05/08 10:00 MHDA- 2001/08/17 10:01 CRDT- 2001/05/08 10:00 PHST- 2001/05/08 10:00 [pubmed] PHST- 2001/08/17 10:01 [medline] PHST- 2001/05/08 10:00 [entrez] AID - 52613 [pii] AID - 10.1159/000052613 [doi] PST - ppublish SO - Exp Nephrol. 2001;9(3):205-13. doi: 10.1159/000052613.